Asia Pacific MedTech (BVI) Ltd 13D/13G Filings for Sorrento Therapeutics, Inc. (SRNE)

Asia Pacific MedTech (BVI) Ltd 13D and 13G filings for Sorrento Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-01
4:34 pm
Sale
2020-12-3113GSorrento Therapeutics, Inc.
SRNE
Asia Pacific MedTech (BVI) Ltd3,549,074
1.300%
-11,768,558decrease
(-76.83%)
Filing